Canada

Canada's Intervention to TRIPS Council: Experience using the System (Apotex-Rwanda Case)

On Wednesday, 27 October 2010, Canada delivered the three interventions to the WTO TRIPS Council related to the review of the Paragraph 6 system. The first intervention below details the Canadian experience using the Paragraph 6 system in the case of Apotex and Rwanda.

CANADA Intervention: (1) Experience using the System (Apotex-Rwanda Case)

As we recall, the 2003 WTO Decision on TRIPS and Public Health was an intensely negotiated decision that garnered unanimous support from all WTO Members.

Patent Protection For Pharmaceutical Products In Canada - Chronology Of Significant Events

A copy of this document is available here:
http://dsp-psd.pwgsc.gc.ca/Collection-R/LoPBdP/BP/prb9946-e.htm

RB 99-46E

PATENT PROTECTION FOR PHARMACEUTICAL PRODUCTS IN CANADA - CHRONOLOGY OF SIGNIFICANT EVENTS

Prepared by:
Margaret Smith
Law and Government Division
30 March 2000

PATENT PROTECTION FOR PHARMACEUTICAL PRODUCTS IN CANADA - CHRONOLOGY OF SIGNIFICANT EVENTS

KEI critical of Canada's Bill C-32 provisions on export of accessible works for persons with disabilities

A new copyright bill in Canada includes extensive provisions about the export of accessible works for persons with a “print disability.” The good news is that they embrace a reasonably good definition of disabilities covered. It goes down hill from there.

KEI on leaked EU Canada trade agreement IPR Chapter

Michael Geist has leaked the lasted draft of the intellectual property chapter of the Canada - EU Comprehensive Economic Trade Agreement. These are some brief comments on the new document.

It applies to both parties.
When a very large trading partner negotiates with a smaller one, it is sometimes overlooked that the norms are designed to bind both parties. So the Canada/EU IPR agreement should be of interest to Canada and the 27 members of the European Union.

KEI RN 2007:2 Recent examples of compulsory licensing of patents


KEI Research Note 2007:2 [1]

(A PDF version of this is available here.)


Recent examples of the use of compulsory licenses on patents[1]

KEI Research Note 2007:2

Canada on disclosure of ACTA documents

Michael Geist reports he has obtained under the Canada Access to Information Act” a confidential November 2008 memorandum written by Stockwell Day, the Canada Minister of International Trade, that says in part:

Canada, US and Italy on [Access to Knowledge] in PCDA discussions

Why are there brackets on A2K?

Paragraph 3 of Cluster B reads:

3. To discuss possible new initatives and strengthen existing mechanisms within WIPO to facilitate [access to knowledge] and technology for developing countries and LDCs and to foster creativity and innovation within WIPO’s mandate.

I talked with Canada during to break, to see where they stood. I can report that Canada was completely negative about removing the brackets from [access to knowledge].

Syndicate content